Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03150836
Title Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Terence Friedlander, MD
Indications

bladder urothelial carcinoma

Therapies

Durvalumab

Durvalumab + Tremelimumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.